Treatments for neurological diseases & disorders
Co-led US$37.25 million Series C (October 2021)
Unlocking the full potential of tech and tech enabled scale-up companies.
Specialising in therapeutics, devices and diagnostics at or near clinical development, with a clear commercial, regulatory and reimbursement pathway.
Venture credit (or venture debt) is a less-dilutive, low cost, complimentary form of capital to equity available to high growth technology and healthcare companies in Australia & New Zealand.
